AGENUS INC Senior Notes, Noncurrent
AGENUS INC (AGEN) had Senior Notes, Noncurrent of $0 as of 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:SeniorLongTermNotes · last filed 2014-03-07
- 2013-12-31: Senior Notes, Noncurrent $0.00.
- 2013-09-30: Senior Notes, Noncurrent $0.00.
- 2013-06-30: Senior Notes, Noncurrent $0.00.
- 2013-03-31: Senior Notes, Noncurrent $36.13M.
| Period end | Senior Notes, Noncurrent |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-07 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-08 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 |
| 2013-03-31 | $36.13M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $35.68M 10-K · filed 2014-03-07 |
| 2012-09-30 | $35.25M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $34.93M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $33.03M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $32.64M 10-K · filed 2013-03-18 |
| 2011-09-30 | $30.82M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $30.46M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $34.05M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |